Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX
· Real-Time Price · USD
5.02
-0.13 (-2.43%)
At close: Aug 15, 2025, 3:59 PM
5.07
1.00%
After-hours: Aug 15, 2025, 05:10 PM EDT
Foghorn Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 24.17M | 23.5M | 22.6M | 25.52M | 35.19M | 33.9M | 34.16M | 32.57M | 21.73M | 20.62M | 19.23M | 15.76M | 9.16M | 4.95M | 1.32M | 857K | 995K | 716K |
Cost of Revenue | n/a | n/a | n/a | 852K | 1.72M | 3.88M | 3.88M | 3.05M | 3.29M | 27.1M | 29.02M | 30.9M | 50.29M | 42.96M | 59.76M | 74.33M | 69.95M | 64.94M |
Gross Profit | 16.62M | 23.5M | 22.6M | 24.66M | 33.47M | 30.01M | 30.27M | 29.52M | 18.44M | -6.48M | -9.79M | -15.14M | -41.13M | -38.01M | -58.44M | -73.48M | -68.96M | -64.22M |
Operating Income | -91.87M | -97.4M | -102.68M | -104.14M | -97.36M | -102.78M | -107.91M | -114.33M | -125.51M | -122.65M | -117.14M | -113.33M | -111.33M | -105.41M | -100.73M | -93.43M | -85.66M | -77.94M |
Interest Income | 11.59M | 12.15M | 11.9M | 11.46M | 10.72M | 10.64M | 10.88M | 8.63M | 7.72M | 6.15M | 3.72M | 3.9M | 2.74M | 2.16M | 2.55M | 2.52M | 2.23M | 1.6M |
Pretax Income | -75.39M | -80.44M | -86.62M | -89.24M | -83.72M | -89.29M | -94.2M | -100.97M | -113.13M | -111.9M | -108.88M | -7.92M | -8.23M | -4.03M | -101.32K | -72.25M | -64.53M | -57.14M |
Net Income | -75.39M | -80.44M | -86.62M | -91.22M | -86.45M | -92.95M | -98.43M | -108.45M | -117.39M | -115.21M | -110.75M | 94.14M | 91.33M | 95.54M | 98.57M | -72.25M | -64.53M | -57.14M |
Selling & General & Admin | 27.43M | 27.89M | 28.36M | 29.03M | 30.36M | 31.44M | 32.37M | 33.21M | 32.87M | 32.17M | 30.75M | 29.22M | 27.06M | 24.25M | 21.73M | 19.95M | 16.7M | 13.71M |
Research & Development | 88.61M | 90.62M | 94.53M | 97.37M | 98.94M | 104.39M | 108.84M | 113.69M | 114.37M | 111.09M | 105.62M | 99.87M | 93.44M | 86.11M | 80.33M | 74.33M | 69.95M | 64.94M |
Other Expenses | n/a | 2.4M | 2.4M | 2.4M | 3.12M | 1.43M | 1.43M | 1.43M | 712K | n/a | n/a | n/a | n/a | n/a | n/a | -7.1M | -7.1M | -7.1M |
Operating Expenses | 116.04M | 120.91M | 125.28M | 128.8M | 131.7M | 135.83M | 141.21M | 146.9M | 147.24M | 143.27M | 136.37M | 27.14M | 18.55M | 8.41M | 102.05K | 54.66M | 47.02M | 39.02M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 426K | 925K | 1.42M | 1.91M | 1.8M | 1.5M | 1.21M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 87.39M | 120.91M | 125.28M | 129.65M | 132.55M | 136.68M | 142.06M | 146.9M | 147.24M | 143.27M | 136.37M | 27.14M | 18.55M | 8.41M | 102.05K | 73.26M | 65.62M | 57.62M |
Income Tax Expense | n/a | n/a | n/a | 1.99M | 2.72M | 3.67M | 4.23M | 7.49M | 4.26M | 3.32M | 1.87M | -102.06M | -99.57M | -99.57M | -98.68M | 20.51M | 20.51M | 20.52M |
Shares Outstanding (Basic) | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M | 41.81M | 41.8M | 41.67M | 41.52M | 41.37M | 36.97M | 36.97M | 36.85M | 36.82M |
Shares Outstanding (Diluted) | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M | 41.81M | 41.8M | 41.67M | 41.52M | 41.37M | 36.97M | 36.97M | 36.85M | 36.82M |
EPS (Basic) | -1.2 | -1.37 | -1.66 | -1.92 | -1.95 | -2.2 | -2.34 | -2.59 | -2.81 | -2.77 | -2.67 | 2.77 | 2.62 | 2.65 | 2.66 | -1.96 | -1.76 | -1.84 |
EPS (Diluted) | -1.2 | -1.37 | -1.66 | -1.92 | -1.95 | -2.2 | -2.34 | -2.59 | -2.81 | -2.77 | -2.67 | 2.77 | 2.62 | 2.65 | 2.66 | -1.96 | -1.76 | -1.84 |
EBITDA | -89.55M | -91.89M | -97.17M | -98.53M | -91.63M | -99.36M | -104.45M | -105.82M | -117.02M | -114.21M | -108.75M | -109.59M | -106.9M | -100.36M | -95.1M | -88.5M | -81.69M | -75.14M |
EBIT | -70.77M | -95M | -100.28M | -101.74M | -94.97M | -102.78M | -107.91M | -111.33M | -122.51M | -119.65M | -114.14M | -113.97M | -111.29M | -104.72M | -99.41M | -91.13M | -83.72M | -76.63M |
Depreciation & Amortization | 2.32M | 3.11M | 3.12M | 3.21M | 3.34M | 4.72M | 4.74M | 6.81M | 7.04M | 6.83M | 7.9M | 6.88M | 7.68M | 7.61M | 7.51M | 6.18M | 4.54M | 2.91M |